ERYTECH announces publication of two articles describing clinical results with eryaspase/GRASPA Post author:admERY Post published:October 20, 2015 Post category:Newsroom ERYTECH announces the publication of two peer-reviewed manuscripts describing clinical results obtained with eryaspase/GRASPA®. You Might Also Like ERYTECH Announces Poster Presentations at ASCO 2020 Annual Meeting June 1, 2020 ERYTECH to Present at the 2021 BIO CEO & Investor Conference February 10, 2021 ERYTECH reports additional positive Phase III results from clinical study with eryaspase/GRASPA® in Acute Lymphoblastic Leukemia December 8, 2014
ERYTECH reports additional positive Phase III results from clinical study with eryaspase/GRASPA® in Acute Lymphoblastic Leukemia December 8, 2014